TY - JOUR
T1 - ITRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine
AU - Yang, Jiankun
AU - Yang, Lichao
AU - Li, Baixue
AU - Zhou, Weilong
AU - Zhong, Sen
AU - Zhuang, Zhenhua
AU - Yang, Bin
AU - Chen, Maoshan
AU - Feng, Quansheng
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Background. Chronic infection with hepatitis B virus (HBV) is a leading cause of cirrhosis and hepatocellular carcinoma. By traditional Chinese medicine (TCM) pattern classification, damp heat stasis in the middle-jiao (DHSM) and liver Qi stagnation and spleen deficiency (LSSD) are two most common subtypes of CHB. Results. In this study, we employed iTRAQ proteomics technology to identify potential serum protein biomarkers in 30 LSSD-CHB and 30 DHSM-CHB patients. Of the total 842 detected proteins, 273 and 345 were differentially expressed in LSSD-CHB and DHSM-CHB patients compared to healthy controls, respectively. LSSD-CHB and DHSM-CHB shared 142 upregulated and 84 downregulated proteins, of which several proteins have been reported to be candidate biomarkers, including immunoglobulin (Ig) related proteins, complement components, apolipoproteins, heat shock proteins, insulin-like growth factor binding protein, and alpha-2-macroglobulin. In addition, we identified that proteins might be potential biomarkers to distinguish LSSD-CHB from DHSM-CHB, such as A0A0A0MS51-HUMAN (gelsolin), PON3-HUMAN, Q96K68-HUMAN, and TRPM8-HUMAN that were differentially expressed exclusively in LSSD-CHB patients and A0A087WT59-HUMAN (transthyretin), ITIH1-HUMAN, TSP1-HUMAN, CO5-HUMAN, and ALBU-HUMAN that were differentially expressed specifically in DHSM-CHB patients. Conclusion. This is the first time to report serum proteins in CHB subtype patients. Our findings provide potential biomarkers can be used for LSSD-CHB and DHSM-CHB.
AB - Background. Chronic infection with hepatitis B virus (HBV) is a leading cause of cirrhosis and hepatocellular carcinoma. By traditional Chinese medicine (TCM) pattern classification, damp heat stasis in the middle-jiao (DHSM) and liver Qi stagnation and spleen deficiency (LSSD) are two most common subtypes of CHB. Results. In this study, we employed iTRAQ proteomics technology to identify potential serum protein biomarkers in 30 LSSD-CHB and 30 DHSM-CHB patients. Of the total 842 detected proteins, 273 and 345 were differentially expressed in LSSD-CHB and DHSM-CHB patients compared to healthy controls, respectively. LSSD-CHB and DHSM-CHB shared 142 upregulated and 84 downregulated proteins, of which several proteins have been reported to be candidate biomarkers, including immunoglobulin (Ig) related proteins, complement components, apolipoproteins, heat shock proteins, insulin-like growth factor binding protein, and alpha-2-macroglobulin. In addition, we identified that proteins might be potential biomarkers to distinguish LSSD-CHB from DHSM-CHB, such as A0A0A0MS51-HUMAN (gelsolin), PON3-HUMAN, Q96K68-HUMAN, and TRPM8-HUMAN that were differentially expressed exclusively in LSSD-CHB patients and A0A087WT59-HUMAN (transthyretin), ITIH1-HUMAN, TSP1-HUMAN, CO5-HUMAN, and ALBU-HUMAN that were differentially expressed specifically in DHSM-CHB patients. Conclusion. This is the first time to report serum proteins in CHB subtype patients. Our findings provide potential biomarkers can be used for LSSD-CHB and DHSM-CHB.
UR - http://www.scopus.com/inward/record.url?scp=85006129586&partnerID=8YFLogxK
U2 - 10.1155/2016/3290260
DO - 10.1155/2016/3290260
M3 - Article
C2 - 28025641
AN - SCOPUS:85006129586
SN - 2314-6133
VL - 2016
JO - BioMed Research International
JF - BioMed Research International
M1 - 3290260
ER -
